Michigan & Utah
TEV-CeD Study
Now enrolling adults with celiac disease to participate in a research study investigating TEV-53408 for the treatment of celiac disease.
TEV-53408 is an investigational antibody designed to block interleukin-15 with the goal of preventing intestinal damage and symptoms that occur when people with celiac disease ingest gluten.
Compensation for time and travel may be available.
Requirements:
- 18-70 years old
- Biopsy-confirmed celiac disease
- On a gluten-free diet
Learn more at tevstudy.celiac.org.